Robert L Young
MD, PhD
- Department of Medicine
- Assistant Professor
- Phone
- 303-398-1263
- Phone 2
- 303-398-1178
- Fax
- 303-270-2319
- Email
- youngb@njhealth.org
- Gender
- Male
Specialties
Adults
Pulmonary/Lung Conditions
Bronchiectasis, Cystic Fibrosis
Research
Cellular and Molecular Biology, Infectious Diseases, Inflammation
Affiliation with University of Colorado Denver
2008–Present: Assistant Professor, Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver
Professional Memberships/Societies
American Thoracic Society
American College of Chest Physicians
Society for Critical Care Medicine
American College of Physicians
Board Certified
1998 and 2008: Internal Medicine
2007: Pulmonary Disease
Critical Care Medicine (anticipated 2008)
Research Interests
Research interests focus on the role of innate immunity in the clearance of pulmonary infections, with a particular interest in the role of the neutrophil and the mechanisms by which it kills microbial pathogens and contributes to pulmonary inflammation.
Service
Education & Training
Education
- Washington University School of Medicine (St. Louis, MO)
- MD, PhD, Molecular Genetics, 1986-1995
- Stanford University (Stanford, CA)
- BS, Medical Microbiology, BA in Economics, 1982-1986
Residencies
- University of Washington (Seattle, WA)
- Internal Medicine, 1995-1998
Fellowships
- University of Colorado Denver
- Pulmonary and Critical Care Medicine, 2005-2008
Awards & Recognition
2008: Cystic Fibrosis Foundation Harry Schwachman Clinical Investigator Award
2008: Viola Vestal Coulter Fellowship, National Jewish Health
2007: Cystic Fibrosis Foundation Third Year Clinical Fellowship
1995: Alpha Omega Alpha
1986 - 1995: Medical Scientist Training Program Fellowship, National Institutes of Health
1986: Phi Beta Kappa
Recent or Important Publications
Parks QM, Young RL, Poch KR, Malcolm KC, Vasil ML, Nick JA. Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J Med Microbiol. 2009 Apr;58(Pt 4):492-502.
Petrovic AS, Young RL, Hilgarth B, Ambros P, Korsmeyer SJ, Jaeger U. The Ig heavy chain 3' end confers a posttranscriptional processing advantage to Bcl-2-IgH fusion RNA in t(14;18) lymphoma. 1998. Blood 91: 3952-61.
Tanner JW, Chen W, Young RL, Longmore GD, Shaw AS. The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. 1995. J. Biol. Chem. 270:6523 6530.
Young RL, Korsmeyer SJ. A negative regulatory element in the bcl-2 5' untranslated region inhibits expression from an upstream promoter. 1993. Mol. Cell. Biol. 13:3686-3697.
Silverman GA, Green ED, Young RL, Jockel JI, Domer PH, Korsmeyer SJ. Meiotic recombination between yeast artificial chromosomes yields a single clone containing the entire bcl-2 protooncogene. 1990. Proc. Natl. Acad. Sci. 87:9913-9917.
